Finally, the levels of genes involved in the tumor EMT, such as CDH2, CDH11, SMAD2, SMAD3, WNT9A, and SP-1, were significantly downregulated after the SH intervention (Fig. 4D). The gene discussed is CDH2; the disease is neoplasm.